Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongqiu Pan

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
BMC Infectious Diseases|November 8, 2014
Obesity-associated gene FTO rs9939609 polymorphism in relation to the risk of tuberculosisYan Feng, Fengliang Wang, Hongqiu Pan, et al.
Pharmacogenetics and Genomics|February 6, 2019
Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han populationHongqiu Pan, Miaomiao Yang, Lihuan Lu, et al.
Journal of Clinical Pharmacology|November 27, 2025
Construction and Validation of a Predictive Model for the Risk of Anti-Tuberculosis Drug-Induced Liver Injury Based on Machine Learning AlgorithmsJingru Cheng, Ruina Chen, Hongqiu Pan, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 11, 2020
Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control studyMiaomiao Yang, Hongqiu Pan, Hongbo Chen, et al.
Frontiers in Genetics|November 8, 2024
Roles of <i>NR1I3</i> and <i>NR1H4</i> polymorphisms in the susceptibility to antituberculosis drug-induced liver injury in China: a case‒control studyXiaoyan Xu, Ruina Chen, Lihuan Lu, et al.
The Journal of Gene Medicine|May 9, 2019
Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han populationLihuan Lu, Bilin Tao, Haixu Wei, et al.
Scientific Reports|June 25, 2016
Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosisMin Wang, Guisheng Xu, Lingshuang Lü, et al.
Journal of Clinical Pharmacology|March 1, 2019
The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug-Induced Hepatotoxicity in Chinese PatientsXiaomin He, Haiping Zhang, Bilin Tao, et al.
Scientific Reports|October 6, 2019
Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control studyShixian Chen, Hongqiu Pan, Yongzhong Chen, et al.
Journal of Gastroenterology and Hepatology|August 6, 2015
Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trialSimin Zhang, Hongqiu Pan, Xianzhen Peng, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
BMC Infectious Diseases|November 8, 2014
Obesity-associated gene FTO rs9939609 polymorphism in relation to the risk of tuberculosisYan Feng, Fengliang Wang, Hongqiu Pan, et al.
Pharmacogenetics and Genomics|February 6, 2019
Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han populationHongqiu Pan, Miaomiao Yang, Lihuan Lu, et al.
Journal of Clinical Pharmacology|November 27, 2025
Construction and Validation of a Predictive Model for the Risk of Anti-Tuberculosis Drug-Induced Liver Injury Based on Machine Learning AlgorithmsJingru Cheng, Ruina Chen, Hongqiu Pan, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 11, 2020
Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control studyMiaomiao Yang, Hongqiu Pan, Hongbo Chen, et al.
Frontiers in Genetics|November 8, 2024
Roles of <i>NR1I3</i> and <i>NR1H4</i> polymorphisms in the susceptibility to antituberculosis drug-induced liver injury in China: a case‒control studyXiaoyan Xu, Ruina Chen, Lihuan Lu, et al.
The Journal of Gene Medicine|May 9, 2019
Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han populationLihuan Lu, Bilin Tao, Haixu Wei, et al.
Scientific Reports|June 25, 2016
Genetic polymorphisms of IL-17A, IL-17F, TLR4 and miR-146a in association with the risk of pulmonary tuberculosisMin Wang, Guisheng Xu, Lingshuang Lü, et al.
Journal of Clinical Pharmacology|March 1, 2019
The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug-Induced Hepatotoxicity in Chinese PatientsXiaomin He, Haiping Zhang, Bilin Tao, et al.
Scientific Reports|October 6, 2019
Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control studyShixian Chen, Hongqiu Pan, Yongzhong Chen, et al.
Journal of Gastroenterology and Hepatology|August 6, 2015
Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trialSimin Zhang, Hongqiu Pan, Xianzhen Peng, et al.
Pageof 5